PREPAID EXPENSES AND OTHER CURRENT ASSETS

3 Months Ended

Jul. 31, 2026

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

PREPAID EXPENSES AND OTHER CURRENT ASSETS

4.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid expenses and other current assets were as follows:


		July 31, 2026				April 30, 2026
Prepaid clinical trial expenses		$	475,035			$	991,850
Prepaid insurance			174,781				41,972
Other prepaid expenses			13,620				19,986
Total prepaid expenses and other current assets		$	663,436			$	1,053,808

Prepaid clinical trial expenses at July 31, 2026, represented the unamortized portion of prepaid clinical trial expense and will be amortized as used, which the Company’s management estimated to be over the next six months.

On June 9, 2026, the Company purchased directors’ and officers’ insurance for 12 months in the amount of $189,000. Prepaid insurance at July 31, 2026 represented the unamortized portion of directors’ and officers’ insurance.